305-307
Antibiotic Effect of Tigecycline on Gram Negative Bacilli
Authors: Sahana Shetty NS, Sumangala B, Mamatha P Samaga, Akshantha B. Sangannavar
Number of views: 388
Introduction: Resistance to multiple antibiotics among Gram negative bacilli (GNB) is high in India. Tigecycline, a
glycylcycline antibiotic is a newer treatment option for emerging single or multidrug-resistant (MDR) GNB.
Material and Methods: All the samples received in the Microbiology laboratory were processed according to standard
protocols. Once identified, they were subjected to antibiotic susceptibility testing by disk diffusion method on Mueller Hinton
agar. We evaluated the in vitro activity of tigecycline and compared it against other antimicrobials. Among 356 isolates,
[Escherichia coli (126), Klebsiella spp (61), Pseudomonas aeruginosa (133), Acinetobacter spp. (23) and Proteus (13)] from
patients with, skin and soft tissue (SSTI) including surgical site, urinary tract and respiratory infections were isolated in our
laboratory, Department of Microbiology, Mandya Institute of Medical Sciences, Mandya. Susceptibility to antimicrobials
besides tigecycline included amikacin, imipenem, levofloxacin, meropenem, and piperacillin/tazobactam was determined by disk
diffusion method.
Results: Tigecycline was active against all E. coli and Klebsiella spp by disc diffusion method. MDR Acinetobacter spp. showed
lower susceptibility (70.6%) to tigecycline and Pseudomonas spp and Proteus spp showed high resistance. Increased resistance
was seen to other antimicrobials among Extended Spectrum Beta Lactamases(ESBL) producing E. coli, Klebsiella spp., Metallo
Beta Lactamase (MBL) producing P. aeruginosa.
Discussion: Tigecycline shows high potency against Gram-negative bacilli belonging to family Enterobacteriaceae in whom
multi-drug resistant strains have emerged as important nosocomial pathogens. Tigecycline is highly active against
Enterobacteriaceae, regardless of the presence or absence of ESBLs, >99% of all of the tested strains were inhibited.In the
present study we found that tigecycline had good activity against tested E.coli and Klebsiella spp.
Conclusion: Tigecycline is an alternative option for emerging multidrug resistant (MDR) pathogens exhibiting promising
spectrum/potency exceeding currently available agents seen in India.